Novo A/S »

Metagenomi shares owned by Novo A/S

Quarter-by-quarter ownership of Metagenomi (MGX) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Metagenomi

Tip: Access up to 7 years of quarterly data

All positions including Metagenomi held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Metagenomi by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.9M 1.8M 2.17
2024-06-30 $7.3M 1.8M 4.08
2024-03-31 $18M 1.7M 10.55

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Tempus Ai Cl A (TEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Vaxcyte (PCVX)
Mirum Pharmaceuticals (MIRM)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Insmed Com Par $.01 (INSM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
Arrivent Biopharma (AVBP)

View all positions for Novo A/S

Top funds holding Metagenomi

Novo A/S
Farallon Capital Management
RA Capital Management
Partner Fund Management
Citadel Advisors
Hillhouse Capital Advisors
Deep Track Capital
BlackRock
BlackRock
Geode Capital Management
ExodusPoint Capital Management
Kestra Advisory Services
Vanguard Group
Renaissance Technologies
Marshall Wace

View all funds holding Metagenomi